Work

A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and docetaxel (D) in patients (pts) with advanced solid tumors

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.3166

Authors: G. Attard, J. J. Kitzen, J. de Bono, J. Verweij, L. Pronk, J. Zhi, S. P. Blagden, S. E. Reade, G. Zugmaier, M. J. de Jonge

Institutions: F. Hoffmann-La Roche AG, Royal Marsden Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2226804220

Cites:

Cited by: 8

Related to: 10